IL1R1 and rheumatoid arthritis: It is well known that IL-1β and the IL-1R are abundant in RA synovium (43); the anti-IL-1β neutralizing monoclonal antibody canakinumab and the recombinant human IL-1R antagonist anakinra show promise in the treatment of RA (7, 8, 44, 45).